| T vs. C | placebo plus SoC | ipilimumab alone | atezolizumab plus SoC | nivolumab plus ipilimumab |
| placebo plus SoC | --- | NA | NA | NA |
| ipilimumab alone | NA | --- | NA | NA |
| atezolizumab plus SoC | NA | NA | --- | NA |
| nivolumab plus ipilimumab | NA | NA | NA | --- |
pathologies: 127
- treatments: 416,864
result logic
